CATB - Catabasis Pharmaceuticals reports Q3 results November, 12 2020 04:50 PM Catabasis Pharmaceuticals Inc. Catabasis Pharmaceuticals (CATB): Q3 GAAP EPS of -$0.56. Cash, equivalents and short-term investments of $52.9M.Press Release For further details see: Catabasis Pharmaceuticals reports Q3 results